These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7071776)

  • 21. [Changes in metabolic function of the liver in patients with chronic hepatic diseases].
    Kupcová V; Holomán J; Turecký L; Ulicná O; Brixová E
    Bratisl Lek Listy; 1985 Jan; 83(1):35-40. PubMed ID: 3967146
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of pharmacologic preparations on hepatic blood flow studied by tetrapolar rheo-hepatography].
    Geller LI; Petrenko VF; Griaznova MV; Bessonova GA
    Ter Arkh; 1988; 60(8):77-9. PubMed ID: 3227483
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacokinetics of phenazone as an indicator of the metabolic capacity of the liver in patients with hyperthyroidism].
    Orzechowska-Juzwenko K; Bolanowski M; Gruszka S; Szymczak J
    Pol Tyg Lek; 1983 May 16-23; 38(20-21):643-5. PubMed ID: 6647129
    [No Abstract]   [Full Text] [Related]  

  • 24. Regression of pancreatic diabetes in chronic hereditary pancreatitis.
    Uhlig HH; Galler A; Keim V; Mössner J; Kiess W; Caca K; Teich N
    Diabetes Care; 2006 Aug; 29(8):1981-2. PubMed ID: 16873815
    [No Abstract]   [Full Text] [Related]  

  • 25. [Influence of rifampicin on the metabolic clearance of galactose and antipyrine as compared with hexobarbital].
    Zilly W; Wernze H; Buchenau D; Breimer DD; Richter E
    Verh Dtsch Ges Inn Med; 1975; 81():1677-80. PubMed ID: 1227056
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.
    Kita Y; Mizukoshi E; Takamura T; Sakurai M; Takata Y; Arai K; Yamashita T; Nakamoto Y; Kaneko S
    Metabolism; 2007 Dec; 56(12):1682-8. PubMed ID: 17998021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activity of the pentose cycle of glucose metabolism in chronic inflammatory diseases of the hepatobiliary system and the pancreas].
    Okorokov AN; Geĭman EV; Chirkin AA; Rabkin MS
    Ter Arkh; 1977; 49(9):88-90. PubMed ID: 929426
    [No Abstract]   [Full Text] [Related]  

  • 28. [Endogenous secretin secretion in chronic pancreatitis, diabetes mellitus and duodenal ulcer].
    Ohara H; Inabe Y; Yabuuchi S; Ota H; Wada T
    Horumon To Rinsho; 1978 Oct; 26(10):1029-35. PubMed ID: 729182
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chronic renal failure as a factor modifying drug metabolism in the body].
    Orzechowska-Juzwenko K; Milejski P; Kazimierczak K; Szewczyk Z
    Pol Tyg Lek; 1986 Dec 22-29; 41(51-52):1638-40. PubMed ID: 3588383
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of benzonal on the drug-metabolizing function of the liver in pathological states].
    Nadzhimutdinov KN; Khakimov ZZ
    Farmakol Toksikol; 1988; 51(3):72-5. PubMed ID: 3410034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Plasma cholecystokinin-pancreozymin assay and the clinical significance].
    Kobayashi K; Nakamura M; Iwata Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():27-9. PubMed ID: 2355545
    [No Abstract]   [Full Text] [Related]  

  • 32. Diabetes mellitus secondary to chronic pancreatitis.
    Larsen S
    Dan Med Bull; 1993 Apr; 40(2):153-62. PubMed ID: 8495594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolic capacity of the liver in chronic alcoholic liver diseases].
    Adamska-Dyniewska H; Biernat S; Kulig A; Szeszko A; Tkaczewski W
    Pol Arch Med Wewn; 1981 Oct; 66(4):265-70. PubMed ID: 7335505
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progression.
    Coverdale SA; Samarasinghe DA; Lin R; Kench J; Byth K; Khan MH; Crewe E; Liddle C; George J; Farrell GC
    Am J Gastroenterol; 2003 Jun; 98(6):1384-90. PubMed ID: 12818285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of vitamin C supplement on antipyrine disposition in man.
    Houston JB
    Br J Clin Pharmacol; 1977 Apr; 4(2):236-9. PubMed ID: 861139
    [No Abstract]   [Full Text] [Related]  

  • 36. [Role of the liver in the regulation of glucose metabolism in diabetes and chronic liver disease].
    Cotrozzi G; Casini Raggi V; Relli P; Buzzelli G
    Ann Ital Med Int; 1997; 12(2):84-91. PubMed ID: 9333317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevalence and significance of type-2 diabetes mellitus in chronic liver disease, correlated with hepatitis C virus].
    Brischetto R; Corno C; Amore MG; Leotta S; Pavone S; Bonsignore L; Calcagno MP; Calcara G
    Ann Ital Med Int; 2003; 18(1):31-6. PubMed ID: 12739426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of accuracy of plasma alpha-amino nitrogen profiles as an indicator of exocrine pancreatic function both after continuous and bolus stimulation of the pancreas with secretin and cholecystokinin-pancreozymin.
    Lembcke B; Konle O; Duan LP; Caspary WF
    Z Gastroenterol; 1994 Dec; 32(12):679-83. PubMed ID: 7871858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Liver capacity in the biotransformation of drugs in patients with chronic circulatory failure (kinetics of antipyrine and indocyanine green)].
    Adamska-Dyniewska H
    Pol Arch Med Wewn; 1978 Oct; 60(4):313-8. PubMed ID: 714726
    [No Abstract]   [Full Text] [Related]  

  • 40. [Oxidative hepatic metabolism in chronic alcoholics during the acute abstinence period: evaluation with antipyrine elimination].
    Soto Alvarez J; Alsar Ortiz MJ
    Rev Clin Esp; 1993 Jun; 193(2):60-3. PubMed ID: 8341815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.